iBio, Inc. (IBIO) vs Tiziana Life Sciences Ltd (TLSA)
A side-by-side comparison of iBio, Inc. and Tiziana Life Sciences Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IBIO
iBio, Inc.
$1.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TLSA
Tiziana Life Sciences Ltd
$1.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IBIO vs TLSA
growth of $100 · dividends reinvested · last 8yIBIO -99.7% (-51.6%/yr)TLSA -74.3% (-15.6%/yr)TLSA compounded faster over this window
Log scale — wide-divergence pair
IBIO TLSA
IBIO vs TLSA: by the numbers
- •TLSA is the larger company ($71M vs $68M market cap).
- •Both run net losses; TLSA's is the smaller (0.00% vs -33044.00% net margin).
Metrics side by side
Valuation
| Metric | IBIO | TLSA |
|---|---|---|
| P/S ratio | 675.23 | N/A |
| P/B ratio | 0.79 | 1358.25 |
Profitability
| Metric | IBIO | TLSA |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -35141.00% | 0.00% |
| Net margin | -33044.00% | 0.00% |
| ROE | -38.55% | -35444.23% |
| ROIC | -40.22% | N/A |
Growth (annualized)
| Metric | IBIO | TLSA |
|---|---|---|
| Revenue CAGR (5Y) | -46.91% | N/A |
| Total return CAGR (5Y) | -70.43% | -5.37% |
Frequently asked
- How have IBIO and TLSA total returns compared?
- Over the past 5 years, IBIO delivered -70.43% and TLSA delivered -5.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.